Given the complementary nature of opioid agonist and antagonist effects, mydriasis (pupil dilation) is often measured as an objective marker of opioid withdrawal severity, with larger pupils corresponding to increased severity of opioid withdrawal (Rosse et al., 1998; Tompkins et al., 2009).